FDA’s recent action plan for illegal drug prescription drugs  In order to prevent harm and protect the public health, US Food and Drug Commissioner Margaret Hamburg announced their plans for a stricter implementation of FDA policies and regulations.

Recent cases involving illegal importation and sales, drug diversion, misbranding of drug products and mislabeling of nutritional supplements have kept the agency busy.

FDA conducted criminal investigations related to the above cases in partnership with other government offices.

Last July 27, Christopher Chase of Massachusetts received a sentence of three years imprisonment with three years of supervised release due to illegal importation of anabolic steroids and other performance enhancing drugs.

The drugs were sourced from China and sold in the United States by Chase and his team as bodybuilding substances through websites. Substances such as anabolic steroids, HGH and IGF-1 were available online without a prescription. Clenbuterol, a known drug not approved by the FDA for human consumption, was also among those drugs sold by Chase’s team.

According to Hamburg, the agency must be vigilant, strategic, and quick and must be visible these days.

Among the FDA’s plan include setting post inspection deadlines, speeding the Warning Letter process, and working more closely with regulatory partners of the agency.

According to PharmTech Talk:

Last month, US Food and Drug Administration Commissioner Margaret Hamburg announced the agency’s six-point plan for tougher enforcement of its policies and regulations as means of protecting public health. The plan, which includes actions like setting postinspection deadlines, speeding the Warning Letter process, and working more closely with FDA’s regulatory partners, was designed to “to prevent harm to the American people,” as Hamburg said in an FDA release.

Comments